Found 34 results
Author Title [ Type(Desc)] Year
Filters: Author is Fast, P  [Clear All Filters]
Conference Paper
P. Hayes, Fernandez, N., Omosa-Manyonyi, G., Mpendo, J., Karita, E., Ruzagira, E., Kilembe, W., Mutua, G., Anzala, O., Roman, F., Bourguignon, P., Barin, B., Eldridge, J., Egan, M., Hannaman, D., Schmidt, C., Fast, P., Priddy, F., Cox, J., and Gilmour, J., Assessment of Viral Inhibition Activity in Low Seroprevalent Adenovirus-35 Vectored HIV Vaccines +/- Adjuvanted Protein or Electroporated DNA, in HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P), Cape Town, SA, 2014.
J. Cox, Farah, B., Langat, R., Indangasi, J., Ogola, S., Onsembe, B., Kopycinski, J., Hayes, P., Borthwick, N., Barin, B., Gilmour, J., De Bont, J., Anzala, O., Fast, P., Reilly, M., Chinyenze, K., Mutua, G., Jaoko, W., and Hanke, T., Broad HIV-1 Inhibition in Vitro by Vaccine-Elicited CD8+ T Cells in African Adults, in HIV R4P 2016, Chicago, IL, 2016.
S. Vasan, Schlesinger, S. J., Chen, Z., Hurley, A., Than, S., Adesanya, P., Bunce, C., Boaz, M., Boyle, R., Sayeed, E., Gardiner, D. F., Zaharatos, G. J., Caskey, M., Q, F., Schmidt, C., Huang, Y., Seamons, L., Ho, M., Lombardo, A., Gilmour, J., Keefer, M. C., Fast, P., and Ho, D. D., Cellular and Humoral Immunogenicity of ADMVA, a Clade C/B MVA-Based HIV-1 Candidate Vaccine, in Healthy Volunteers, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
O. G Manyonyi, Jaoko, W., Wakasiaka, S., Bwayo, J., Achola, N. J., Schmidt, C., Bhatt, K., Ogutu, H., K’owino, D., Dally, L., Malogo, R., and Fast, P., Challenges Experienced By the Clinical Team During The Conduct of HIV Vaccine Clinical Trials in Kenya, in AIDS Vaccine 2005 International Conference, Montreal, Quebec, Canada, 2005.
H. Ogutu, Wakasiaka, S., Malogo, R., Ndambuki, R., Nyange, J., Omosa, G., Anzala, O., Bwayo, J., Fast, P., Schmidt, C., Verlinde, C., Smith, C., Ndinya-Achola, J., and Jaoko, W., Challenges of Use and Compliance With Effective Contraceptives Among Female Participants in Preventive HIV Vaccine Trials: The Kenyan Experience, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
E. Karita, Anzala, O., Gazzard, B., Bergin, P., Nyombayire, J., Omosa, G., ,, Dally, L., Barin, B., Inoue, M., Hara, H., Hironaka, T., Shu, T., Hasegawa, M., Matano, T., Sayeed, E., Parks, C., Ackland, J., Fast, P., Gilmour, J., Cox, J., Lombardo, A., and Laufer, D., Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G(NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers, in HIVR4P (HIV Research for Prevention), Cape Town, South Africa, 2014.
V. D. Ramanathan, Kumar, M., Jayashri, M., Sathyamoorthy, P., Narayanan, P. R., Solomon, S., Cox, J., Sayeed, E., Ackland, J., Verlinde, C., Vooijs, D., Loughran, K., Barin, B., Lombardo, A., Gilmour, J., Stevens, G., Kochhar, S., Excler, J., and Fast, P., A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara (rMVA) Virus Preventive Multigenic HIV Subtype C Vaccine (TBC-M4) in Indian Volunteers, in Keystone Symposia Global Health Series: Pathogenesis and Control of Emerging Infections and Drug Resistant Organisms, Bangkok, Thailand, 2008.
E. Vardas, Kaleebu, P., Bekker, L., Hoosen, A., Chomba, E., Johnson, P., Heald, A., Anklesaria, P., Dally, L., Boaz, M., Fast, P., and Schmidt, C., A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant Adeno-Associated Virus HIV Vaccine, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
B. Peters, Jaoko, W., Anzala, O., Judges, L., G Manyonyi, O., Sharp, A., Gray, K., Fast, P., Schmidt, C., Gilmour, J., Smith, C., Dally, L., Loughran, K., Farah, B., Tarragona, T., Hayes, P., McMichael, A., Hanke, T., and Bwayo, J., Phase 2A Dose and Route Study of a DNA Prime MVA Boost Vaccine Candidate, in AIDS Vaccine 2005 International Conference, Montreal, Quebec, Canada, 2005.
V. Ramanathan, Kumar, M., Mahalingam, J., Narayanan, P., Solomon, S., Boaz, M., Sayeed, E., Scharton-Kersten, T., Seth-Smith, M., Verlinde, C., Vooijs, D., Barin, B., Lombardo, A., Kochhar, S., Excler, J., and Fast, P., A Phase I Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara Virus (TBC-M4) Multigenic HIV Subtype C Vaccine, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
A. Guimarães-Walker, Mackie, N., McMichael, A., Weber, J., McCormack, S., Cebere, I., Kay, R., Hanke, T., Dally, L., Gibiansky, L., Legg, K., DeSouza, C., Hayes, P., Gilmour, J., and Fast, P., Priming with a Candidate HIV-1 Clade A DNA Vaccine Followed by Boosting with an HIV-1 Clade A MVA Vaccine in Volunteers at Low risk of HIV Infection, in AIDS Vaccine 2004 International Conference, Lausanne, Switzerland, 2004.
R. Belshe, Bolognesi, D., Clements, M., Corey, L., Fast, P., Graham, B., Keefer, M., Mestecky, J., Mulligan, M., and Stablein, D., Progress in HIV-1 Vaccine Development, in 2nd National Conference on Human Retroviruses and Related Infections, Washington DC, 1995.
E. Vardas, Pantaleo, G., Bart, P. A., Robinson, A., Pieterse, C., Thomas, R., McIntyre, J., Gray, G., Bogoshi, M., Mayaphi, S., Fast, P., Schmidt, C., Gilmour, J., Tarragona, T., Smith, C., and Dally, L., Safety and Immunogenicity of MVA.HIVA by 3 Different Routes, in AIDS Vaccine 2005 International Conference, Montreal, Quebec, Canada, 2005.
W. Jaoko, Kayitenkore, K., G Manyonyi, O., Karita, E., Schmidt, C., Fast, P., Komaroff, W., Cooper, A., Boaz, M., Gilmour, J., Dally, L., Ho, M., Smith, C., and Graham, B., Safety and Immunogenicity of VRC Multiclade HIV-1 Adenoviral Vector Vaccine Alone or with VRC Multiclade HIV-1 DNA Plasmid Vaccine in the African Adults, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
G. Mutua, Hanke, T., Fast, P., Hannaman, D., Chinyenze, K., Oino, G., Sajabi, R., Verlinde, C., Barin, B., Reilly, M., and Jaoko, W., Safety and Tolerability of pSG2.HIVconsv DNA MVA.HIVconsv and Ad35-GRIN Prime-Boost Combinations Administered to Healthy HIV-Uninfected Kenyan Adults, in HIV R4P 2016, Chicago, IL, 2016.
S. Vasan, Hurley, A., Schlesinger, S., Hannaman, D., Gardiner, D., Dugin, D., Huang, Y., Andersen, J., Caskey, M., Evans, C., Dolter, K., Schmidt, C., Fast, P., and Ho, D., Safety, Tolerability, and Acceptability of Electroporation to Deliver ADVAX, a Clade C/B’ DNA-Based Candidate HIV-1 Vaccine, to Healthy Volunteers, in AIDS Vaccine 2008 Conference, Cape Town, South Africa, 2008.
P. Kitandwe, Farah, B., Bizimana, J., Karita, E., Mutua, G., Mpendo, J., Omosa-Manyonyi, G., Bekker, L. G., L Baden, G., Lehrman, J., Laufer, G., Roman, F., Barin, B., Schmidt, C., Fast, P., Cox, J., Priddy, F., and Gelderblom, H., Vaccine Induced HIV Seropositivity/Reactivity (VISP/R) Among Recipients of Adenovirus Vectored HIV-1 Vaccine Prime/Boost Regimens, in HIV R4P 2016, Chicago, IL, 2016.
Journal Article
G. Omosa-Manyonyi, Park, H., Mutua, G., Farah, B., Bergin, P. J., Laufer, D., Lehrman, J., Chinyenze, K., Barin, B., Fast, P., Gilmour, J., and Anzala, O., Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya, PLoS One, vol. 9, p. e110228, 2014.
B. S. Graham, McElrath, M. J., Connor, R. I., Schwartz, D. H., Gorse, G. J., Keefer, M. C., Mulligan, M. J., Matthews, T. J., Wolinsky, S. M., Montefiori, D. C., Vermund, S. H., Lambert, J. S., Corey, L., Belshe, R. B., Dolin, R., Wright, P. F., Korber, B. T., Wolff, M. C., and Fast, P., Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines, J Infec Dis, vol. 177, pp. 310-319, 1998.
W. Stevens, Kamali, A., Karita, E., Anzala, O., Sanders, E. J., Jaoko, W., Kaleebu, P., Mulenga, J., Dally, L., Fast, P., Gilmour, J., Farah, B., Birungi, J., Hughes, P., Manigart, O., Stevens, G., Yates, S., Thomson, H., ,, Stoll-Johnson, L., and Ketter, N., Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials, PLoS ONE, vol. 3, p. e2043, 2008.
T. G. Evans, Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., Graham, B. S., McElrath, M. J., Clements-Mann, M. L., Mulligan, M. J., Fast, P., Walker, M. C., Excler, J. L., Duliege, A. M., and Tartaglia, J., A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers, J Infec Dis, vol. 180, no. 2, pp. 290-298, 1999.
E. Karita, Ketter, N., Price, M., Kayitenkore, K., Kaleebu, P., Nanvubya, A., Anzala, O., Jaoko, W., Mutua, G., Ruzagira, E., Mulenga, J., Sanders, E., Mwangome, M., Allen, S., Bwanika, A., Bahemuka, U., Awuondo, K., Omosa, G., Farah, B., Amornkul, P., Birungi, J., Yates, S., Stoll-Johnson, L., Gilmour, J., Stevens, G., Shutes, E., Manigart, O., Hughes, P., Dally, L., Scott, J., Stevens, W., Fast, P., and Kamali, S., CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa, PLoS ONE, vol. 4, no. 2, p. e4401, 2009.
M. L. Clements-Mann, Weinhold, K., Matthews, T. J., Graham, B. S., Gorse, G. J., Keefer, M. C., McElrath, M. J., Hsieh, R. H., Mestecky, J., Zolla-Pazner, S., Mascola, J., Schwartz, D., Siliciano, R., Corey, L., Wright, P. F., Belshe, R., Dolin, R., Jackson, S., Xu, S., Fast, P., and Walker, M., Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults, J Infec Dis, vol. 177, pp. 1230-46, 1998.
B. Graham, McElrath, M., Keefer, M., Rybczyk, K., Berger, D., Weinhold, K., Ottinger, J., Ferarri, G., Montefiori, D., Stablein, D., Smith, C., Ginsberg, R., Eldridge, J., Duerr, A., Fast, P., and Haynes, B., Immunization With Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, But Causes Sterile Abscesses and Unacceptable Reactogenicity, PLoS One, vol. 5, no. 8, p. e11995, 2010.
S. Vasan, Hurley, A., Schlesinger, S. J., Hannaman, D., Gardiner, D. F., Dugin, D. P., Boente-Carrera, M., Clark, L., Dally, L., Smith, C., Schmidt, C., Park, H. H., Kopycinski, J. T., Gilmour, J., Fast, P., Bernard, R., and Ho, D. D., In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers, PLoS One, vol. 6, p. e19252, 2011.